13D Filings
Home
FAQ
Ikena Oncology, Inc.
IMA
Amendment
Ownership

1.90%

Total Shares

220,832

Issuer CIK

1835579

CUSIP

45175G207

Event Date

Jul 24, 2025

Accepted

Jul 28, 2025, 02:16 PM

SEC EDGARView Original Filing
Reporting Persons (2)
NameType% of ClassAggregateSole VotingShared Voting
BML Investment Partners, L.P.
Partnership
1.90%215,8320215,832
Leonard Braden Michael
Individual
1.90%220,8325,000215,832
Disclosure Items (6)

Security Title

Common Stock, par value $0.001 per share

Issuer Name

Ikena Oncology, Inc.

Issuer Address

645 Summer Street, Suite 101, Boston, MA, 02210

Filing Persons

BML Investment Partners, L.P. Braden M. Leonard - Mr. Leonard's business address is 65 E Cedar Suite 2, Zionsville, IN 46077. Mr. Leonard's principal business is to serve as managing member of BML Capital Management, LLC.

Business Address

65 E Cedar - Suite 2 Zionsville, IN 46077

Principal Occupation

See Above

Convictions

During the past five years, none of BML Investment Partners, L.P., BML Capital Management, LLC or Braden M. Leonard have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding BML Investment Partners, L.P., BML Capital Management, LLC or Braden M. Leonard was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Citizenship

Braden M. Leonard is a citizen of the United States of America. BML Investment Partners, L.P. is a Delaware limited partnership.

BML Investment Partners, L.P. holds 215832 shares of Common Stock which were acquired using $4.3 million of working capital. Braden M Leonard holds 5,000 shares of Common Stock which were acquired using $94,800 of working capital.

All of the Common Stock of the Issuer reported on this Schedule 13D was acquired in the ordinary course of business by the reporting persons for investment purposes. The reporting persons have no present plans or proposals that relate to or would result in any of the actions described in Item 4(a) through (j) of Schedule 13D. The reporting persons may evaluate on a continuing basis the investment in the Issuer and may, from time to time, acquire or dispose of Common Stock of the Issuer. Any such acquisitions or dispositions will depend upon (i) the price and availability of the Issuer's securities; (ii) subsequent developments concerning the Issuer's business and prospects and the industry in which the Issuer operates; (iii) investment policies of the reporting persons; (iv) other investment opportunities available to the reporting persons; (v) general market and economic conditions; (vi) tax considerations; and (viii) such other factors as the reporting persons may deem relevant. Any such acquisitions or dispositions may be made, subject to applicable law, in open market transactions. On July 25th, the Issuer completed the transaction with Inmagene. The reporting person is no longer a 5% holder.

Percentage of Class

BML Investment Partners, L.P. beneficially owns 215,832 shares of the Issuer's Common Stock, or 8.35%. Braden M Leonard owns 5,000 shares of the Issuer's Common Stock.

Number of Shares

BML Investment Partners, L.P. 4,030,102 Braden M Leonard 60,000

Transactions

BML Investment Partners, L.P. Date Activity Quantity Price 7/16/2025 Sell -169872 1.3 7/16/2025 Sell -150000 1.3 7/17/2025 Sell -120514 1.29 7/17/2025 Sell -150000 1.28 7/21/2025 Sell -300000 1.25 7/22/2025 Sell -49724 1.2548 7/22/2025 Sell -500000 1.2

Shareholders

Braden M Leonard is the Managing Member of BML Capital Management, LLC, which is the General Partner to BML Investment Partners, L.P.

Date of 5% Ownership

N/A

To the best of the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.